New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Intuitive Surgical, Inc.

ISRG

Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.

Revenue
+21.7%
EPS
−23.6%
Free cash flow
+51.0%

Quarter to September 2026, against a year earlier

399.33 7.91 −1.94%

After hours trading: 400.00, up 0.17%, last trade 4:23pm Eastern.

Market cap
$141.2B
P/E
47.8×
Fwd P/E FY26e
51.3×
Dividend yield
—
F-score
7/9
ROIC
17.0%
Net debt / EBITDA
−1.6×
Payout ratio
—

Revenue to profit Q3 FY2026, quarter to Sep 30, 2026

Of every $100 of revenue, $17.20 was left as profit. Gross margin has risen two quarters running, from 66.1% to 68.4%. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue3.0100.0%
Cost of revenue−1.0−31.6%
Gross profit2.168.4%
Research & development−0.4−13.4%
Selling, general & admin−0.6−20.8%
Other operating costs−0.5−14.8%
Operating income0.619.4%
Other income, net+0.12.5%
Income tax−0.1−4.7%
Net income0.517.2%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$2.9B$2.8B$2.9B$3.0B
Operating income$864M$855M$972M$593M
Net income$800M$826M$823M$524M
Net margin (right axis)27.9%29.8%28.5%17.2%
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Revenue
3,048.70 2,892.30 2,770.80 2,866.20

+8 more quarters

Revenue Growth
21.70% 18.54% 22.96% 18.76%
Cost of Revenue
964.40 931.90 940.30 961.90
Gross Profit
2,084.30 1,960.40 1,830.50 1,904.30
R&D Expenses
408.30 370.60 361.90 352.90
SG&A Expenses
633.40 617.90 613.30 687.10
Operating Income
592.60 971.90 855.30 864.30
Non-operating Income/Expense
75.80 82.70 85.10 91.30
EBT
668.40 1,054.60 940.40 955.60
Income Tax Provision
144.00 231.40 114.40 156.10
Income after Tax
524.40 823.20 826.00 799.50
Dividends (Preferred)
0.00 0.00 — —
Non-Controlling Interest
1.60 5.10 4.50 4.70
Net Income Common
522.80 818.10 821.50 794.80
EPS (Basic)
1.50 2.31 2.31 2.24
EPS (Diluted)
1.49 2.29 2.28 2.21
Shares (Basic, Weighted)
349.00 354.10 354.90 356.90
Shares (Diluted, Weighted)
351.60 357.30 359.80 362.70
Gross Margin
68.37% 67.78% 66.06% 66.44%
EBIT Margin
19.44% 33.60% 30.87% 30.15%
EBT margin
21.92% 36.46% 33.94% 33.34%
Net Profit Margin
17.15% 28.29% 29.65% 27.73%
EBITDA
796.40 1,194.20 1,045.10 1,100.10
EBIT
592.60 971.90 855.30 864.30
Income from Continuous Operations
524.40 823.20 826.00 799.50
Consolidated Net Income/Loss
524.40 823.20 826.00 799.50
EPS (Basic, from Continuous Ops)
1.50 2.32 2.33 2.25
EPS (Diluted, from Cont. Ops)
1.49 2.30 2.30 2.22
EPS (Basic, Consolidated)
1.50 2.32 2.33 2.25
EPS (Diluted, Consolidated)
1.49 2.30 2.30 2.22
Shares (Diluted, Average)
351.60 357.30 359.80 360.40
EBITDA Margin
26.12% 41.29% 37.72% 38.38%
Operating Cash Flow Margin
40.15% 36.68% 32.91% 31.14%

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 2, 2026